Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

Restored skin may feed bacterial growth and prolong deeper skin damage

In human skin with an , restored may feed and prolong deeper damage despite normal water loss and . Confirmed without an between and bacterial lipid use would refute this .

Stage of verification

  1. Hypothesis published2026-09-25
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionSkin

Ageing mechanism

Main connectionDysbiosis

Direction

Kind of knowledge gap

The available measurement is only an indirect stand-in for what matters.Proxy gap

A double ring marks the main placement where a group contains several values.

Lens
Microbial lipid assimilation
Goal
Ограничение накопительного ущерба от повторного восстановления
Competing hypotheses
1
Published
2026-09-25
As a hypothesis
8 / 10Clarity of mechanism
10 / 10Few extra conditions
9 / 10Completeness of the answer
5 / 10Novelty of the idea
10 / 10Few new entities
9 / 10Decisive experiment
2 / 10Silver-bullet potential
4 / 10Support from research
Poster: Lipids fuel bacterial growth
PosterOpen the sheet full size2026-09-26

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Metabolism and energy

    Bacterial utilization of exogenous

    The incorporation of external into bacterial to support bacterial growth

    Where this hypothesis actsPersistent during repeated of aged skin

    Hypotheses on this target 1
    Bacterial utilization of exogenous fatty acidsInhibition. Hypotheses on this target 11Activation. Hypotheses on this target 0Function preservation. Hypotheses on this target 0Supplementation. Hypotheses on this target 0Feedback restoration. Hypotheses on this target 0Direct measurement. Hypotheses on this target 0
    • Inhibition1
    • Activation
    • Function preservation
    • Supplementation
    • Feedback restoration
    • Direct measurement

    What is proposed

    Inhibition

    Limit bacterial incorporation of external into

    With whatControlled genetic model

    HowGenetically disrupt bacterial use of external , using independent approaches and function-restored bacterial variants as controls

    Possible result

    Possible stabilization of and reduced recurrent

    From the recordЭтот дополнительный эффект должен исчезать при нарушении бактериального использования внешних жирных кислот и возвращаться после восстановления соответствующей функции.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstructionBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acids
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Skin that holds water normally may still be undergoing damage beneath its surface. The unexpected move is that replacing , the fats and related substances that help protect skin, might also supply material for persistent bacteria to grow. That explanation is a proposal generated by this pipeline, not a measured result in repaired, middle-aged human skin.

The proposed mechanism, link by link
  1. Replacing protective skin fats would make available to persistent bacteria.
  2. The bacteria would incorporate those into their membrane .
  3. That supply would sustain additional bacterial growth during skin repair.
  4. The additional growth would prolong deeper skin damage despite normal water retention and active .
  5. Restricting bacterial use of the supplied fats would remove the added growth and reduce repeated deeper damage.
A picture for it

Repairing a protective fence could also leave building materials available to an unwanted occupant. The fence can work again while those materials help the occupant expand.

Where the picture breaks: Skin fats can themselves help restrain bacteria. Their availability and incorporation do not establish that they produce additional bacterial growth or tissue damage.

  1. Master questionstep 01 of 04

    A treatment is sought that would bring the functioning of middle-aged human skin closer to that of young skin.

    Rests on: The supplied goal explicitly names improved skin function and young people as the comparison.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    Limiting damage that accumulates through repeated repair is selected as a route toward younger skin function.

    Rests on: The goal requires identifying processes that prevent middle-aged skin from functioning like young skin.

    Assumption

    The chain assumes that repeated repair produces accumulating damage relevant to the desired improvement; the master question itself does not establish that connection.

  3. Gap questionstep 03 of 04

    Restoring the skin's resistance to water loss might leave deeper damage unresolved if a shared failure to release protective fats and substances that act against microbes persists. The question locates that damage in the , the deeper skin layer beneath the surface.

    Rests on: The preceding stage identifies damage from repeated repair as the target.

    Leap

    The preceding stage does not supply the connection between repeated repair, a shared failure to release protective substances, and continued deeper damage despite normal water loss. The supplied source records do not establish that combination.

  4. Hypothesisstep 04 of 04

    Restored skin fats are proposed to supply , components used to build fats, that persistent bacteria incorporate into , the fat-based molecules forming their surrounding membranes. This could sustain bacterial growth and deeper damage even when water loss, release of protective substances by skin cells, and the activity of , short proteins that act against microbes, remain normal.S1S2

    Rests on: The preceding question supplies the possibility of damage despite restored water retention. For the proposed alternative mechanism, S1 in Journal of Bacteriology (2018) reports bacterial incorporation of from human fat-carrying particles in culture, and S2 in Journal of Bacteriology (2020) reports incorporation from host tissue, including experiments using broken-up mouse skin; neither establishes added growth or deeper injury during repair of middle-aged human skin.

    Supported by literature

What is carried, and what is not. Two screened studies, S1 and S2, directly support the incorporation link under the limited conditions described above; they do not establish the proposed sequence from skin repair to additional growth and deeper damage. S6 in JID Innovations (2022), discussing inflammatory skin disease, describes protective effects of skin fats against bacterial growth, without settling their net effect during repair of aging skin; no supplied source establishes this proposal end to end.S1S2S6

Where the reasoning is carried by something unstated · 2
  • Goal pillar. The chain assumes that repeated repair produces accumulating damage relevant to the desired improvement; the master question itself does not establish that connection.
  • Gap question. The preceding stage does not supply the connection between repeated repair, a shared failure to release protective substances, and continued deeper damage despite normal water loss. The supplied source records do not establish that combination. Establish the missing link before relying on this step.
How a result here could mislead · 3
  • Detecting a chemical label from supplied inside bacteria could be mistaken for evidence that those fats caused additional growth or injury. What closes it: The specified , which follows atoms distinguishable by their mass, must be interpreted alongside net increases in living bacteria and subsequent deeper damage. The decisive comparison is whether restoring fats adds these effects when bacterial fat use is intact, loses them when that ability is disrupted, and regains them when it is restored.
  • A genetically altered bacterium could grow less or cause less harm for reasons other than its inability to use supplied fats. What closes it: The design calls for several independent ways to disrupt fat use and for restoration of the affected function. Each comparison must establish the change in fat incorporation and account for independent changes in bacterial growth and capacity to cause damage.
  • Matching water loss and surface chemistry could be read as proof that protective peptide activity is normal, leaving the rival explanation falsely excluded. What closes it: The design matches , acidity and the concentration and electrical charge of dissolved salts, but does not explicitly specify direct measurement of peptide activity or skin-cell release of protective substances. Those functions must be checked during the growth and injury measurements to establish the intact defenses claimed by the hypothesis.

What would make this wrong. The supplied hypothesis specifies that confirmed incorporation of labeled without a joint effect of fat restoration and bacterial fat-use ability on added growth and subsequent damage would refute the claimed of incorporation. That conclusion requires verified disruption and restoration of fat use and accounting for independent effects of the bacterial alterations.

What it would change. If the proposed sequence held, restoring water retention alone would be an incomplete measure of progress toward younger skin function: the same replacement fats could support persistent bacteria and repeated deeper injury. Work toward the master goal would then need to distinguish barrier recovery from recovery without bacterial growth supported by those fats. An initial laboratory result using donor material from people aged 40–60 and a young comparison would still not establish a treatment's effectiveness in living people or its safety over decades; the proposed outcome called is not defined in the supplied material.

Sources read · 10

3 literature searches, 5 full texts, 5 abstract-only; 10 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1Partly answers it

Staphylococcus aureus Utilizes Host-Derived Lipoprotein Particles as Sources of Fatty Acids. · Journal of bacteriology · 2018

“Using mass spectrometry, we observed that host-derived fatty acids present in the LDLs are incorporated into the staphylococcal membrane and that tolerance to triclosan is facilitated by the fatty acid kinase A, FakA, and Geh, a triacylglycerol lipase.”

Does not settle: Источник устанавливает использование жирных кислот из человеческих липопротеинов в культуре S. aureus. Он не устанавливает, что липиды восстанавливающейся возрастной кожи питают бактерии, поддерживают их размножение или продлевают повреждение дермы при сохранных барьерных и противомикробных функциях. Он также не проверяет SPV_6 и эффект ограничения использования липидов на повторное повреждение дермы.

S2Partly answers it

Exogenous Fatty Acids Remodel Staphylococcus aureus Lipid Composition through Fatty Acid Kinase. · Journal of bacteriology · 2020

“We show that wild-type S. aureus can incorporate exogenous unsaturated fatty acids from host tissue, highlighting the importance of FakA in the presence of host skin tissue.”

Does not settle: Источник не устанавливает, что восстановление возрастной кожи создаёт преимущество для S. aureus, поддерживает его размножение или продлевает повреждение дермы. Опыты с гомогенатом кожи мыши не подтверждают перенос результата на человека, повторное восстановление кожи, сохранность барьера, антимикробных пептидов или SPV_6.

S3Background

A fatty acid-binding protein of Streptococcus pneumoniae facilitates the acquisition of host polyunsaturated fatty acids. · The Journal of biological chemistry · 2019

“We determined the Sp FakB1- and Sp FakB2-binding proteins were bioinformatically related to the two binding proteins of Staphylococcus aureus , and biochemical and X-ray crystallographic analysis showed that Sp FakB1 selectively bound saturates, whereas Sp FakB2 allows the activation of monounsaturates akin to their S. aureus counterparts.”

Does not settle: Текст не исследует Staphylococcus aureus в коже человека, восстановление возрастной кожи, поток липидов из эпидермиса, бактериальный рост, повреждение дермы или влияние ограничения использования липидов на SPV_6.

S4Partly answers itAbstract only

A new pathway of exogenous fatty acid incorporation proceeds by a classical phosphoryl transfer reaction. · Molecular microbiology · 2014

“Parsons and co-workers show that in Staphylococcus aureus exogenous fatty acids are activated by phosphoryl transfer from ATP to form acyl-phosphates, a mixed anhydride suggested as a potential intermediate 70 years ago.”

Does not settle: This abstract does not establish that restored skin lipids supply these fatty acids, that their incorporation supports bacterial growth during skin repair, or that it prolongs dermal damage despite normal barrier, secretion, or antimicrobial-peptide activity. It does not test lipid-use restriction, SPV_6, human aged skin, or tissue-repair outcomes.

S5BackgroundAbstract only

pH in nature, humans and skin. · The Journal of dermatology · 2018

“Later on, it was found that the pH influences skin barrier function, lipid synthesis and aggregation, epidermal differentiation and desquamation.”

Does not settle: This abstract does not establish that restored skin lipids feed Staphylococcus aureus, that the bacteria incorporate those lipids into phospholipids, or that limiting lipid use prevents recurrent dermal damage.

S6Contradicts it

Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis. · JID innovations : skin science from molecules to population health · 2022

“Extracellular matrix lipids (e.g., FFAs and sphingomyelin) contribute to the antimicrobial barrier by limiting bacterial growth, maintaining acidic pH, and activating AMPs”

Does not settle: Whether restored physiological lipids in aging skin can be incorporated into S. aureus phospholipids, support its growth during tissue repair, prolong dermal damage despite preserved barrier measures and AMPs, or whether limiting lipid use stabilizes SPV_6.

S7Contradicts it

Staphylococcus aureus causes aberrant epidermal lipid composition and skin barrier dysfunction. · Allergy · 2023

“S . aureus -mediated aberrant lipid profiles cause increased TEWL and skin barrier dysfunction.”

Does not settle: Источник не устанавливает, что восстановленные липиды кожи включаются S. aureus в фосфолипиды, поддерживают его размножение или что ограничение их использования стабилизирует SPV_6 и уменьшает повреждение дермы.

S8BackgroundAbstract only

Skin microbiome dysbiosis and the role of Staphylococcus aureus in atopic dermatitis in adults and children: A narrative review. · Journal of the European Academy of Dermatology and Venereology : JEADV · 2023

“Additionally, local skin anatomy, lipid content, pH, water activity and sebum secretion differ between children and adults and generally correlate with the predominant microbiota.”

Does not settle: Источник не устанавливает, что восстановление липидов возрастной кожи создаёт преимущество для Staphylococcus aureus, что бактерии включают доступные жирные кислоты в фосфолипиды или что ограничение этого использования уменьшает повреждение дермы.

S9BackgroundAbstract only

Ichthyosis. · Nature reviews. Disease primers · 2023

“The resultant skin barrier dysfunction leads to increased transepidermal water loss and inflammation.”

Does not settle: Источник оставляет открытыми роль восстановленных липидов, использование жирных кислот Staphylococcus aureus, бактериальный рост, повреждение дермы и влияние ограничения этого процесса на SPV_6.

S10BackgroundAbstract only

Nicotinic acid/niacinamide and the skin. · Journal of cosmetic dermatology · 2004

“Topical application of niacinamide has a stabilizing effect on epidermal barrier function, seen as a reduction in transepidermal water loss and an improvement in the moisture content of the horny layer.”

Does not settle: Источник не устанавливает, используют ли Staphylococcus aureus липиды восстановленной кожи для синтеза фосфолипидов, поддерживает ли это размножение бактерий или продлевает повреждение дермы. Также не проверяются антимикробные пептиды, сохранность секреции кератиноцитов и влияние ограничения использования липидов на SPV_6.

The gap this hypothesis explains

What is measured here stands in for what matters, and may not track it.

Does restoring skin’s water barrier stop deeper damage, or can faulty secretion leave immune defenses weakened?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Устраняет ли восстановление распространение повреждения в , или общий дефект и сохраняет иммунную уязвимость при нормальной потере воды?

What this question is asking

The question concerns whether skin that retains water normally has also recovered its protection against further injury. It asks whether restoring the water barrier stops damage from spreading into the , the deeper skin layer, or whether impaired release of fats and substances that fight microbes leaves immune protection weakened. The decisive comparison is between recovery of water retention and recovery of deeper tissue and immune protection after treatment. The question assumes that a shared secretion defect could underlie both water loss and weakened defenses, so correcting water loss might leave that defect unresolved. The intended setting is middle-aged human skin, but the supplied findings concern particular skin diseases, experimental injury, and measurements of barrier function.

What the terms mean
Water barrier and water loss
The water barrier is the skin's ability to restrict water escaping through it. Water loss measures that outward escape; normal water retention is the proposed sign of recovery, but the input provides no numerical definition of normal.
Dermis
The skin layer beneath the epidermis, or outer skin layer. The question asks whether injury continues into this deeper tissue after water retention recovers.
Secretion
The release of materials from cells or glands. Producing a substance and releasing it are different steps, so evidence of reduced production does not by itself establish a secretion defect.
Lipids
A class of fatty substances, including materials involved in the skin's water barrier. The question concerns whether their release shares a defect with release of substances involved in protection against microbes.
Antimicrobial factors and antimicrobial peptides
Antimicrobial factors are substances involved in defense against microbes, such as bacteria and fungi. are short protein-like molecules within that broad class; changes in them do not alone measure the entirety of immune protection.
Immune vulnerability
Reduced ability of the body's defenses to limit harmful challenges. Here it is an outcome that might remain abnormal after water retention improves, rather than a condition directly demonstrated by the supplied findings.
Inflammation
A tissue response involving immune activity. Its reduction is one reported treatment outcome, but it is distinct from demonstrating restored protection against microbes.
Rosacea and papulopustular rosacea
Rosacea is an inflammatory skin condition; papulopustular rosacea is a form with raised bumps and pus-containing spots. The human samples and mouse models described here concern this disease setting rather than ordinary skin aging.
Hyaluronan
A chain-forming sugar-based molecule. S2 concerns treatment with short pieces of those chains, called oligosaccharides.
Filaggrin
A protein associated with the outer skin barrier. Its increase accompanies reduced water loss in S2, but that finding does not establish recovery of immune protection.
Atopic dermatitis
An inflammatory skin condition also called atopic eczema. S7 studies an experimentally induced version in mice, while S8 discusses it in relation to stress.
Lamellar bodies
Small structures within skin cells involved in releasing materials for the outer barrier. S8 reports reduced secretion from them, and S7 describes a treatment system intended to mimic them.
Antibody
A protein produced by the immune system. A decrease in the antibody measurement reported in S7 is an immune-related change, not a direct demonstration that protection against microbes has recovered.
What the question takes for granted
Premise only partly supported
A shared defect in secretion of and antimicrobial factors may cause both impaired water retention and immune vulnerability, with vulnerability potentially persisting after water loss returns to normal.

are fats involved in the skin barrier, and antimicrobial factors are substances that help defend against microbes; secretion is their release from cells or glands. The assumption is that a common failure in releasing these protective materials could affect both water retention and immune protection. If that failure persisted after water loss improved, the water measurement alone would not establish complete recovery.

S4 reports changes in both structural barrier components and in rosacea samples. S8 reports decreased secretion from lamellar bodies alongside reduced production of , but reduced production is not itself proof of defective secretion of those peptides. These findings support linked disturbances in barrier and protective components, a narrower claim than a single shared secretion defect. S9 describes water loss as a measure of outward barrier function; none of these sources establishes persistent immune vulnerability after water loss has normalized.S4S8S9

The same question asked without the part nothing read establishes:

  • After water loss returns to normal in middle-aged human skin, does deeper tissue damage stop, and is protection against microbes restored?
  • Does normal water loss coincide with restored release of skin and antimicrobial substances?
What turns on the answer
  • Water retention and protection recover together If the intervention corrects the failure responsible for both water leakage and weakened protection, improved retention would accompany restored defenses and cessation of deeper damage. In that setting, normal water loss would coincide with broader recovery, although coincidence alone would not establish that water retention caused the other improvements.
  • Water retention recovers but vulnerability persists If water retention improves while release of protective substances remains impaired, the water measurement would record recovery of only one function. Persistent immune vulnerability would mean that normal water loss could not establish complete protection; whether deeper damage actually continues would remain a separate outcome.
  • Deeper damage stops but immune protection remains impaired Stopping damage from spreading and restoring defenses against microbes could have different outcomes. If deeper injury ceased while protective secretion remained impaired, water retention and tissue recovery would still not establish full immune recovery.
Why it matters

The proposed chain begins with impaired release of substances involved in water retention and protection against microbes. If restoring water retention also corrects the relevant protective failure, deeper injury could stop along with the improvement in water loss. If protective secretion remains impaired, a normal water-loss measurement could coexist with unresolved vulnerability; this is the possibility being asked about, not an outcome demonstrated by the supplied sources. Treating water loss as proof of complete recovery could therefore misclassify skin protection, while assuming persistent vulnerability without measuring it could also misclassify recovery.

What is already established

Карты потери воды, RL-3, измеряют ; , RL-2, не устанавливает полноценность иммунной защиты и .

What would have to be true

Иммунная защита ограничивает последствия за заданные часы и дни; вовлечение и остаточное повреждение остаются ниже допустимых границ.

What is missing

Не установлено, означает ли нормализация потери воды устранение причины или лишь коррекцию одного проявления общего .

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

Проверяемая гипотеза: при повторном восстановлении возрастной кожи восполнение само создаёт преимущество для сохраняющегося . Бактерии включают доступные в собственные и тем самым поддерживают размножение во время восстановления ткани. Поэтому повреждение может продолжаться при нормальной потере воды, нормальной и сохранной активности . представляет собой поток липидного материала из восстановленного поверхностного слоя в . Предполагается, что ограничение этого использования стабилизирует и уменьшит повторное повреждение .

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

В с сравнивают и с одинаковыми потерей воды, , кислотностью и . При одинаковой должно увеличивать в бактериальные , чистый и последующее повреждение . Этот дополнительный эффект должен исчезать при нарушении бактериального использования внешних и возвращаться после восстановления соответствующей функции. Сравнивают « × бактериальная способность использовать », учитывая самостоятельное влияние на рост и . Отсутствие такого при подтверждённом опровергнет . без изменения , согласно этой гипотезе, не устранит дополнительный рост.

States a measurable outcome; comparing rivals needs more conditions. The prediction specifies directional changes under matched conditions, loss and restoration of the additional effect, and an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

, и сопоставление исходных, изменённых и восстановленных позволяют проверить причинную цепь. Первую проверку проводят в с материалом доноров 40–60 лет и . Генетическая проверка требует нескольких независимых подходов, поскольку изменение влияет на разные свойства бактерий. Краткосрочный результат не устанавливает десятилетнюю безопасность терапии.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

В с сравнивают и с одинаковыми потерей воды, , кислотностью и . При одинаковой должно увеличивать в бактериальные , чистый и последующее повреждение . Этот дополнительный эффект должен исчезать при нарушении бактериального использования внешних и возвращаться после восстановления соответствующей функции. Сравнивают « × бактериальная способность использовать », учитывая самостоятельное влияние на рост и . Отсутствие такого при подтверждённом опровергнет . без изменения , согласно этой гипотезе, не устранит дополнительный рост.

  • What would separate them

    High ionic strength may disable skin antimicrobial peptides and sustain dermal damage predicts: При одинаковых потере воды, составе, кислотности и количестве должна восстанавливаться после без усиления . Обратное изменение солевого состава должно воспроизводить потерю активности в . В это восстановление должно предшествовать снижению и уменьшению повреждения . Усиление с одинаковой чувствительностью к солевой среде даст меньший эффект, чем добавление независимо проверенного защитного компонента, сохраняющего активность в этой среде. Если измеренный солевой состав не снижает активность либо его нормализация не улучшает уничтожение бактерий, гипотеза опровергается.

Why this is not the mainstream account

The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.

Empirical anchor

В экспериментальном исследовании использовал кожи для обхода определённых ограничений собственного ; значимость этого пути проверяли при поверхностной инфекции у мышей. Это поддерживает возможность механизма, но не доказывает вред восстановления кожи человека. [Исследование использования кожи](https://pubmed.ncbi.nlm.nih.gov/33753501/). Существенное ограничение: в другой модели инфекции выключение использования внешних не уменьшало рост бактерий. [Исследование в очаге инфекции](https://pmc.ncbi.nlm.nih.gov/articles/PMC7240157/).

Subfield revised

восстановления кожи, учебный раздел « и восстановление защитных функций». Пересмотра потребовало бы сильное утверждение, что полное физиологическое способно причинно усиливать инфекционное повреждение даже после независимого подтверждения нормальной и кожи. Тогда восстановленного материала стала бы самостоятельным критерием полноценности восстановления.

Testable surprise

Кожа с восстановленными и противомикробной повреждается сильнее именно вследствие восстановления ; эффект исчезает при избирательном прекращении бактериального использования этих и возвращается при восстановлении этого пути.

Why this is not the mainstream account

Строгое доказательство отсутствия такой позиции в литературе получить нельзя. Использование бактериями уже установлено и само по себе не является еретическим тезисом. В выполненном поиске не найдено подтверждения более сильного утверждения о вреде функционально полного возрастной кожи при сохранной . Статус HERETICAL остаётся предварительным; неполное совпадение с найденными публикациями не доказывает новизну.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionStates a measurable outcome; comparing rivals needs more conditionsTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.